
|Articles|March 1, 2004
Ms. Codit
We get many faxes regarding issues that don't warrant that I dedicate an entire column to their responses. Many of these questions can answered with simple "yes' and "no" answers. I have collected the questions and will dedicate the next few months to answering them. I refer to them as "Dermatology Potpourri." Enjoy!
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma
5











